Results 201 to 210 of about 170,290 (313)
Endovascular treatment for posterior epistaxis: should it still be considered a last-resort option? A literature review. [PDF]
Martinez HR +11 more
europepmc +1 more source
Degradomics for large‐scale mechanistic insights on proteases and proteolysis in human health
Proteolysis has an important role in human disease but remains relatively unexplored. Degradomics, the uncovering of proteolysis in tissues, cells, and proteins, uses mass spectrometry‐based terminomics to identify protein termini occurring therein (forward degradomics) and to define the actions of proteases (reverse degradomics).
Daniel R. Martin +2 more
wiley +1 more source
Development and validation of a nomogram for predicting early rupture and rebleeding risk after intracranial aneurysm embolization. [PDF]
Du P, Yu F, Chen G, Xu W.
europepmc +1 more source
A New Experimental Model of ARDS and Pulmonary Hypertension in the Dog [PDF]
Forst, Helmuth +3 more
core +1 more source
Middle Meningeal Artery Embolization as Standalone Therapy for Chronic Subdural Hematoma with Radiological Herniation Features: A Case Report. [PDF]
Soetanto GW, Wiyarta E.
europepmc +1 more source
Abstract Objective This study was conducted to provide a clinically oriented, mechanism‐based framework for interpreting neuroimaging across disorders of cerebrospinal fluid (CSF) pressure, with particular emphasis on patients who fall between classic diagnostic categories of spontaneous intracranial hypotension (SIH) and idiopathic intracranial ...
Andrew L. Callen, Kyle Jenkins
wiley +1 more source
Embolization Followed by Self-Repositioning of a CardioMEMS™ Wireless Pulmonary Artery Hemodynamic Monitoring Sensor Device. [PDF]
Kharsa C +5 more
europepmc +1 more source
ABSTRACT Background There is a paucity of data regarding the efficacy and safety of lenvatinib as a second‐line treatment following first‐line combination immunotherapy with durvalumab and tremelimumab (Dur + Tre). Methods This retrospective multicenter study included 14 patients with unresectable hepatocellular carcinoma who received lenvatinib after ...
Ryoichi Miura +21 more
wiley +1 more source

